Free Trial

Acacia Research (ACTG) Stock Price, News & Analysis

-0.03 (-0.54%)
(As of 05/28/2024 ET)
Today's Range
50-Day Range
52-Week Range
196,094 shs
Average Volume
222,346 shs
Market Capitalization
$552.11 million
P/E Ratio
Dividend Yield
Price Target

Acacia Research MarketRank™ Stock Analysis

Analyst Rating
3.00 Rating Score
26.8% Upside
$7.00 Price Target
Short Interest
0.91% of Shares Sold Short
Dividend Strength
News Sentiment
0.73mentions of Acacia Research in the last 14 days
Based on 6 Articles This Week
Insider Trading
Acquiring Shares
$103,104 Bought Last Quarter
Proj. Earnings Growth

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.42 out of 5 stars

Business Services Sector

77th out of 311 stocks

Patent Owners & Lessors Industry

2nd out of 8 stocks

ACTG stock logo

About Acacia Research Stock (NASDAQ:ACTG)

Acacia Research Corporation, together with its subsidiaries, invests in intellectual property and related absolute return assets; and engages in the licensing and enforcement of patented technologies. The company operates through three segments, Intellectual Property Operations, Industrial Operations, and Energy Operations. The company owns or controls the rights to various patent portfolios, which include U.S. patents and foreign counterparts covering technologies used in a range of industries. It also owns, manufactures, and distributes printers and consumable products through dealers and distributors for various industrial printing applications. In addition, the company offers supply-chain printing solutions for manufacturing, transportation and logistics, retail distribution, food and beverage distribution, and pharmaceutical distribution industries; and line matrix printers for mission critical applications within labeling and inventory management, build sheets, invoicing, manifests and bills of lading, and reporting industries. Further, it involved in the acquisition, production and development of oil and gas assets. Acacia Research Corporation was incorporated in 1993 and is headquartered in New York, New York.

ACTG Stock Price History

ACTG Stock News Headlines

Under $5 Gems: 3 Stocks Ready for a Radical Rise
Acacia Research earnings: here's what to expect
Acacia Research Corp
Acacia Research Shares Up 14% After 4Q Report
Q4 2023 Acacia Research Corp Earnings Call
See More Headlines
Receive ACTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acacia Research and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Patent owners & lessors
Research & Consulting Services
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
1 Analysts


Net Income
$67.06 million
Pretax Margin


Sales & Book Value

Annual Sales
$125.10 million
Cash Flow
$0.50 per share
Book Value
$5.90 per share


Free Float
Market Cap
$552.11 million

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

ACTG Stock Analysis - Frequently Asked Questions

Should I buy or sell Acacia Research stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Acacia Research in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" ACTG shares.
View ACTG analyst ratings
or view top-rated stocks.

What is Acacia Research's stock price target for 2024?

1 brokerages have issued 1 year target prices for Acacia Research's stock. Their ACTG share price targets range from $7.00 to $7.00. On average, they anticipate the company's share price to reach $7.00 in the next twelve months. This suggests a possible upside of 26.8% from the stock's current price.
View analysts price targets for ACTG
or view top-rated stocks among Wall Street analysts.

How have ACTG shares performed in 2024?

Acacia Research's stock was trading at $3.92 at the beginning of 2024. Since then, ACTG stock has increased by 40.8% and is now trading at $5.52.
View the best growth stocks for 2024 here

Are investors shorting Acacia Research?

Acacia Research saw a increase in short interest in May. As of May 15th, there was short interest totaling 914,100 shares, an increase of 28.0% from the April 30th total of 714,000 shares. Based on an average trading volume of 254,300 shares, the short-interest ratio is currently 3.6 days.
View Acacia Research's Short Interest

When is Acacia Research's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 1st 2024.
View our ACTG earnings forecast

How were Acacia Research's earnings last quarter?

Acacia Research Co. (NASDAQ:ACTG) posted its quarterly earnings data on Thursday, May, 9th. The business services provider reported $0.06 EPS for the quarter. The business services provider had revenue of $24.32 million for the quarter. Acacia Research had a trailing twelve-month return on equity of 13.02% and a net margin of 40.89%.

What ETF holds Acacia Research's stock?

Formidable ETF holds 395,924 shares of ACTG stock, representing 8.57% of its portfolio.

What other stocks do shareholders of Acacia Research own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Acacia Research investors own include Trevena (TRVN), Advanced Micro Devices (AMD), Coeur Mining (CDE), Extreme Networks (EXTR), OPKO Health (OPK), Palatin Technologies (PTN), Rigel Pharmaceuticals (RIGL), Arrowhead Pharmaceuticals (ARWR) and Catalyst Pharmaceuticals (CPRX).

Who are Acacia Research's major shareholders?

Acacia Research's stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (2.25%), Pacific Ridge Capital Partners LLC (1.05%), Tidal Investments LLC (0.50%), Krilogy Financial LLC (0.47%), Levin Capital Strategies L.P. (0.22%) and Empowered Funds LLC (0.17%). Insiders that own company stock include Jason W Soncini, Kirsten Hoover, Marc W Booth, Martin D Jr Mcnulty and Richard Jay Rosenstein.
View institutional ownership trends

How do I buy shares of Acacia Research?

Shares of ACTG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ACTG) was last updated on 5/29/2024 by Staff

From Our Partners